mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
6e-05 |